Overview

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and peripheral stem cell transplantation in treating patients who have multiple myeloma.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Robert H. Lurie Cancer Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Cyclophosphamide
Cytarabine
Etoposide
Interferon-alpha
Interferons
Melphalan
Criteria
DISEASE CHARACTERISTICS: All stages of multiple myeloma Measurable disease manifested by
monoclonal serum or urine globulins If nonsecretory, must have malignant plasma cells
documented on bilateral bone marrow biopsy or isolated plasmacytomas Complete remission to
induction chemotherapy allowed No progressive disease after standard induction therapy

PATIENT CHARACTERISTICS: Age: Physiologic 65 and under Performance status: CALGB 0-1 Life
expectancy: Not specified Hematopoietic: Not specified Hepatic: Bilirubin no greater than
2.0 mg/dL No active hepatitis with hepatitis C Renal: Creatinine less than 2.0 mg/dL OR
Creatinine clearance at least 50 mL/min Cardiovascular: LVEF at least 45% No history of
symptomatic coronary artery disease unless cleared after cardiology evaluation Pulmonary:
FEV1 at least 60% predicted FEV1/FVC at least 60% Other: HIV negative Hepatitis B surface
antigen negative

PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: See Disease
Characteristics No more than 2 prior chemotherapy regimens, including induction Endocrine
therapy: Not specified Radiotherapy: Not specified Surgery: Not specified